Natural Product: NPC239549

Natural Product IDNPC239549
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
7-O-[Alpha-L-Rhamnopyranosyl-(1->2)-Beta-D-Glucopyranosyl]-1,8-Dihydroxy-3-Methoxyxanthone
IUPAC Name 2-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-1,8-dihydroxy-6-methoxyxanthen-9-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL2409395
PubChem CID 71745329
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey COOBKIBQQIIVKX-YBJOZTBGSA-N
Standard InCHI InChI=1S/C26H30O15/c1-8-17(29)21(33)23(35)25(37-8)41-24-22(34)19(31)14(7-27)40-26(24)39-12-4-3-11-16(18(12)30)20(32)15-10(28)5-9(36-2)6-13(15)38-11/h3-6,8,14,17,19,21-31,33-35H,7H2,1-2H3/t8-,14+,17-,19+,21+,22-,23+,24+,25-,26+/m0/s1
SMILES OC[C@H]1O[C@@H](Oc2ccc3c(c2O)c(=O)c2c(o3)cc(cc2O)OC)[C@@H]([C@H]([C@@H]1O)O)O[C@@H]1O[C@@H](C)[C@@H]([C@H]([C@H]1O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   582.16 Volume:   528.868
?
Van der Waals volume.
Dense:   1.101 LogP:   0.13
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.013
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.887
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   6.0 Rigid Bonds:   29.0
TPSA:   238.2
?
Topological Polar Surface Area.
H-Bond Acceptor:   15.0
H-Bond Donor:   8.0 Rings:   5.0
Heavy Atoms:   15.0

MedChem Properties

QED Drug-Likeness Score:   0.153 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.712 Fsp3:   0.5
MCE-18:   119.436
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   1 PAINS Alert:   0
Colloidal aggregators:   0.613 Fluc inhibitor:   0.26
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.663
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.479
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.139 Promiscuous compounds:   0.451

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.354 MDCK Permeability:   -5.295
Pgp-inhibitor:   0.0 Pgp-substrate:   0.865
PAMPA:   0.989
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.88
20% Bioavailability (F20%):   0.08 30% Bioavailability (F30%):   0.978
50% Bioavailability (F50%):   0.994

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.001 MRP1:   0.079
Plasma Protein Binding (PPB):   78.311% Volume Distribution (VD):   -0.231
Fu: 19.36%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.999
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.296
BSEP inhibitor:   0.005

ADMET: Metabolism

CYP1A2-inhibitor:   0.002 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.003 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.297
HLM stability:   0.218
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  1.31 Half-life (T1/2):  3.497

ADMET: Toxicity

hERG Blockers:  0.013 hERG Blockers (10um):  0.09
Human Hepatotoxicity (H-HT):  0.512 Drug-induced Liver Injury (DILI):  0.985
AMES Toxicity:  0.908 Rat Oral Acute Toxicity:  0.021
Maximum Recommended Daily Dose:  0.012 Skin Sensitization:  0.991
Carcinogencity:  0.158 Eye Corrosion:  0.0
Eye Irritation:  0.406 Respiratory Toxicity:  0.008
Drug-induced Neurotoxicity:  0.0 Ototoxicity:  0.918
Hematotoxicity:  0.185 Drug-induced Nephrotoxicity:  0.332
Genotoxicity:  0.454 RPMI-8226 Immunitoxicity:  0.14
A549 Cytotoxicity:  0.249 Hek293 Cytotoxicity:  0.192
BCF:   0.433
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.116
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.803
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.925
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9824 Swertia kouitchensis Species Gentianaceae Eukaryota n.a. n.a. n.a. PMID[23805995]
NPO9824 Swertia kouitchensis Species Gentianaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO9824 Swertia kouitchensis Species Gentianaceae Eukaryota n.a. n.a. n.a. Database[TCMID]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT497 Individual protein Maltase-glucoamylase Homo sapiens IC50 = 75800.0 nM PMID[30282319]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified n.a. IC50 > 1717000.0 nM PMID[25682561]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC239549 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.6237 Remote Similarity NPC240306
0.618 Remote Similarity NPC267254
0.5979 Remote Similarity NPC195257
0.5851 Remote Similarity NPC65003
0.5789 Remote Similarity NPC115674
0.5612 Remote Similarity NPC32641
0.5612 Remote Similarity NPC256188
0.5568 Remote Similarity NPC210042
0.5541 Remote Similarity NPC180234
0.5524 Remote Similarity NPC311850
0.5463 Remote Similarity NPC198199
0.5455 Remote Similarity NPC35119
0.5347 Remote Similarity NPC475382
0.525 Remote Similarity NPC607702
0.5229 Remote Similarity NPC68592
0.5208 Remote Similarity NPC8856
0.5179 Remote Similarity NPC120952
0.5152 Remote Similarity NPC470444
0.5109 Remote Similarity NPC22195
0.5109 Remote Similarity NPC21190
0.5098 Remote Similarity NPC142142
0.5096 Remote Similarity NPC135358
0.5049 Remote Similarity NPC220173

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC239549 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data